Effect of No-Reflow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction on Six-Month Mortality
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary
2004 • 8,563 citations
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
1989 • 8,119 citations
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
2003 • 4,290 citations
TIMI Frame Count
1996 • 1,789 citations
ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction
2004 • 1,265 citations
Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction
2000 • 561 citations
Incidence and treatment of 'no-reflow' after percutaneous coronary intervention.
1994 • 520 citations
TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study.
1993 • 289 citations
Features and outcome of no-reflow after percutaneous coronary intervention
1995 • 286 citations
No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention
2003 • 247 citations
Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty
1995 • 184 citations
Incidence and Importance of Thrombolysis in Myocardial Infarction Grade 3 Flow After Primary Percutaneous Transluminal Coronary Angioplasty for Acute Myocardial Infarction
1996 • 45 citations
Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial)
2004 • 39 citations
Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarction
2006 • 36 citations